DHIVY was designed with your unique needs in mind

2 doctors developed DHIVY using a patented technology

Click below to view the 3D Pill Model to understand more about DHIVY’s unique design.

DHIVY is functionally scored, so it’s made to be broken
With deep grooves, DHIVY was designed to break evenly and cleanly
Firm enough not to break accidentally

DHIVY provides daily carbidopa/
levodopa (CD/LD) dosing flexibility at your fingertips

DHIVY can be taken whole or in segments

Take DHIVY as prescribed by your doctor.

If you need a whole tablet of DHIVY:

Swallow the tablet whole. If you have trouble swallowing a whole tablet, you can snap DHIVY into segments.

Drawing of 2 hands holding a DHIVY tablet

Image does not represent the actual size of the tablet.

If you need to snap DHIVY into segments:

Ensure you are holding the tablet in both hands, then gently push downward on each side of the tablet’s groove.

Watch the video to learn more about how to snap a DHIVY tablet.

DHIVY is a CD/LD tablet designed to be divided

In one snappable tablet, DHIVY provides a range of segments.

Divide your daily dose to fit your day

1 whole tablet

(25 mg/100 mg)

3/4 tablet

(18.75 mg/75 mg)

1/2 tablet

(12.5 mg/50 mg)

1/4 tablet

(6.25 mg/25 mg)

1/4 of DHIVY is the smallest segment available within a 25 mg/100 mg CD/LD tablet

Images do not represent the actual size of the tablet.

Learn how you can save on DHIVY.

Get started

Tips on how to take DHIVY

If breaking DHIVY for a segmented dose, place the remainder of the tablet somewhere safe for later use.

Take DHIVY with or without food.

Store DHIVY at room temperature in a tightly closed container that’s protected from light and moisture.

Talk to your doctor before making any adjustments to your medications.

DHIVY has similar side effects to
other forms of CD/LD. See side effects

DHIVY — the CD/LD tablet made to be broken

ClickTap each hot spot and drag to rotate the tablet to learn more about DHIVY's unique design.

Accessibility Controls

Rotate

Hot Spots

Text Transcript

Front view is the side of a pill with 3 v-shaped grooves evenly spaced so that the pill is divided into quarters.

IMPORTANT SAFETY INFORMATION & INDICATION

Do not take DHIVY with antidepressant medications known as nonselective monoamine oxidase (MAO) inhibitors because taking these two drugs within 2 weeks of each other can result in high blood pressure. Do not take DHIVY if you have hypersensitivity to any ingredient of DHIVY.

Taking DHIVY may result in falling asleep while engaged in normal activities, even without warning and as late as one year or later after starting DHIVY. Do not drive or operate machinery until you know how DHIVY affects you.

Tell your healthcare provider if you have any heart conditions, especially if you have had a heart attack or irregular heartbeats; if you experience hallucinations or abnormal thoughts and behaviors (such as excessive suspicion, believing things that are not real, confusion, agitation, aggressive behavior, and disorganized thinking); if you have intense urges to gamble, increased sexual urges, other intense urges, and the inability to control those urges; if dyskinesia or abnormal involuntary movements appear or get worse during treatment with DHIVY; if you develop symptoms such as depression, confusion, cheilosis, glossitis, dermatitis, anemia, neuropathy, and/or seizures (which may be a vitamin B6 deficiency); if you have ever had a peptic ulcer or glaucoma; if you have any abnormal lab results; or if you experience depression or suicidal thoughts.

Notify your healthcare provider if you become pregnant or intend to become pregnant during DHIVY therapy or if you intend to breastfeed or are breastfeeding an infant.

Talk to your healthcare provider before you lower the dose or stop taking DHIVY, as this may result in serious side effects. Call your healthcare provider immediately if you develop withdrawal symptoms such as fever, confusion, or severe muscle stiffness.

Take DHIVY as instructed. You may take DHIVY with or without food. If you have difficulty swallowing the tablet due to its size, you may break the tablet along the score lines.

The most common adverse reactions reported with carbidopa/levodopa tablets have included abnormal involuntary movements and nausea.

INDICATION

DHIVY is a combination of carbidopa and levodopa indicated for the treatment of Parkinson’s disease, postencephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

You may report side effects to Avion Pharmaceuticals, LLC at 1-888-612-8466 or to the FDA at 1-800-FDA-1088.

Please click here for full Prescribing Information.